Pseudoalteromonas haloplanktis TAC125 produces 4-hydroxybenzoic acid that induces pyroptosis in human A459 lung adenocarcinoma cells

Abstract

In order to exploit the rich reservoir of marine cold-adapted bacteria as a source of bioactive metabolites, ethyl acetate crude extracts of thirteen polar marine bacteria were tested for their antiproliferative activity on A549 lung epithelial cancer cells. The crude extract from Pseudoalteromonas haloplanktis TAC125 was the most active in inhibiting cell proliferation. Extensive bioassay-guided purification and mass spectrometric characterization allowed the identification of 4-hydroxybenzoic acid (4-HBA) as the molecule responsible for this bioactivity. We further demonstrate that 4-HBA inhibits A549 cancer cell proliferation with an IC 50 value ≤ 1 μg ml −1 , and that the effect is specific, since the other two HBA isomers (i.e. 2-HBA and 3-HBA) were unable to inhibit cell proliferation. The effect of 4-HBA is also selective since treatment of normal lung epithelial cells (WI-38) with 4-HBA did not affect cell viability. Finally, we show that 4-HBA is able to activate, at the gene and protein levels, a specific cell death signaling pathway named pyroptosis. Accordingly, the treatment of A549 cells with 4-HBA induces the transcription of (amongst others) caspase-1, IL1β, and IL18 encoding genes. Studies needed for the elucidation of mode of action of 4-HBA will be instrumental in depicting novel details of pyroptosis.Lung cancer is an extremely important health concern that affects millions of people worldwide 1,2 , and any progress leading to improvement of cancer survival rates is a global priority. Patients with lung cancer generally have a poor prognosis with a 5-year survival 2 . Traditional cancer chemotherapy has mainly been based on the use of highly cytotoxic drugs that non-specifically target all dividing cells and may therefore only result in a modest improvement in patients that become immunosuppressed as chemotherapeutics kill all proliferating cells including monocytes and lymphocytes. For this reason, a new trend in anticancer research has arisen focusing on the discovery of new natural drugs that induce specific programmed cell death mediated by immunogenic signals. A recently discovered form of immunogenic cell death is represented by pyroptosis. This pathway differs from that of apoptosis as it is uniquely mediated by caspase-1 (CASP1) activation, which in turn triggers the formation of an "inflammasome", a cytosolic complex with inflammatory features 3 linked to interleukin 1β (IL1β) release for immune cell recruitment.

Challenging microalgal vitamins for human health

“…Microalgae have the potential to fill many of the global demand regarding different fields (e.g., nutraceuticals, energy, animal feed) being considered as valuable biofactories [ 217 ]. Increasing literature assessed that microalgae cover antiviral, antitumor, antioxidant, anti-inflammatory, antiallergenic, antidiabetic, and antibacterial properties [ 218 – 220 ]. So far, the limitations of developing industrial microalgal biotechnology are mainly represented by the high production costs [ 221 , 222 ].…”

Marine Proteobacteria as a source of natural products: advances in molecular tools and strategies

“…Additionally, P. haloplanktis has recently been demonstrated to natively produce anticancer-active 4-hydroxybenzoic acid. 150 In a similar study, Yu et al 74 developed a cold-adapted expression system in Pseudoalteromonas sp. BSi20429 and successfully expressed the active form of pseudoalterin, a cold-adapted enzyme.…”

Evaluation of process involved in the production of aromatic compounds in Gram‐negative bacteria isolated from vanilla ( Vanilla planifolia ex. Andrews) beans

“…Moreover some micro‐organisms can produce or degrade AC like vanillin and HBA. Also, there are Gram‐negative and Gram‐positive bacteria that produce vanillin from FA like precursors and, on rare occasions, they produce HBA and can utilize AC as a defense mechanism to inhibit competing bacterial growth (Chen et al ; Kallscheuer and Marienhagen ; Sannino et al ; Shin et al ).…”